Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants (Q34985957)

5 August 2017

1 reference

title

Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants (English)

1 reference

5 August 2017

1 reference

chronic fatigue syndrome

1 reference

Alessandro Serretti

6

0 references

author name string

Chi-Un Pae

1

1 reference

5 August 2017

David M Marks

2

1 reference

5 August 2017

Ashwin A Patkar

3

1 reference

5 August 2017

Prakash S Masand

4

1 reference

5 August 2017

Patrick Luyten

5

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Expert Opinion on Pharmacotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

10

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1561-1570

1 reference

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Customizing treatment of chronic fatigue syndrome and fibromyalgia: the role of perpetuating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Predictors of response to treatment for chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Alexithymia in chronic fatigue syndrome: associations with momentary, recall, and retrospective measures of somatic complaints and emotions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Sleep quality and psychological adjustment in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

The role of life stress in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Prognostic factors for persons with idiopathic chronic fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Mortality in a cohort of chronically fatigued patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Causes of death among patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Disability and chronic fatigue syndrome: a focus on function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Illness and disability in Danish Chronic Fatigue Syndrome patients at diagnosis and 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Cytokines, stress and depressive illness: brain‐immune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

The immunoregulatory effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

The relationship between fibromyalgia and major depressive disorder: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Duloxetine: a new psychopharmacologic treatment option for fibromyalgia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

An investigation of the long-term benefits of antidepressant medication in the recovery of patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Chronic Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Development of a fatigue scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine--a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Bupropion for fatigue and as a tumor necrosis factor-alpha lowering agent in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Selegiline transdermal system: current awareness and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Does methylphenidate reduce the symptoms of chronic fatigue syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Treatment of chronic fatigue syndrome: findings, principles and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Irritable bowel syndrome in psychiatric perspectives: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

Mania and recovery from chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902988510

10.1517/14656560902988510

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference